InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-38.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Campoy Carlos, Chief Financial Officer. Insider active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 6 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €3k. History available since 31 May 2021. The latest transaction was disclosed on 16 March 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
1,748 shares@ US$1.97919.0% of flowCommon StockSEC:0001140361-23-012617:0
15,000 shares0Common StockSEC:0001567619-22-014296:0
22,500 shares0Common StockSEC:0001567619-22-002522:0
22,500 shares0Common StockSEC:0001567619-22-002522
3,320 shares@ US$6.0860.0023% mcap50.0% of flowCommon StockSEC:0001567619-21-011807:0
3,320 shares@ US$6.08645.5% of flowCommon StockSEC:0001567619-21-011807
6 of 6 declarations
About Campoy Carlos
Carlos Campoy is the Chief Financial Officer of CytomX Therapeutics, Inc. In this role, he is responsible for the financial management of the company, including financial planning, risk management, and regulatory compliance. Campoy works closely with management to ensure the financial health of the company and support its growth strategy.
